We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SLV.WAR

Price
30.90
Stock movement up
+0.20 (0.65%)
Company name
Selvita S.A.
Exchange
(WAR
,
Currency
PLN
)
Sector
Healthcare >
Diagnostics & Research
Market cap
567.18M
Ent value
879.45M
Price/Sales
1.74
Price/Book
1.79
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
11.97
Forward P/E
20.46
PEG
-
EPS growth
42.32%
1 year return
-53.53%
3 year return
-27.47%
5 year return
-0.38%
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

SLV.WAR does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E11.97
Price to OCF7.40
Price to FCF18.15
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.74
Price to Book1.79
EV to Sales2.70

FINANCIALS

Per share

Loading...
Per share data
Current share count18.36M
EPS (TTM)2.58
FCF per share (TTM)1.70

Income statement

Loading...
Income statement data
Revenue (TTM)325.28M
Gross profit (TTM)255.15M
Operating income (TTM)-1.41M
Net income (TTM)47.40M
EPS (TTM)2.58
EPS (1y forward)1.51

Margins

Loading...
Margins data
Gross margin (TTM)78.44%
Operating margin (TTM)-0.43%
Profit margin (TTM)14.57%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash14.42M
Net receivables60.54M
Total current assets120.02M
Goodwill90.58M
Intangible assets84.25M
Property, plant and equipment272.61M
Total assets642.76M
Accounts payable39.27M
Short/Current long term debt0.00
Total current liabilities106.79M
Total liabilities326.69M
Shareholder's equity316.07M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)76.67M
Capital expenditures (TTM)45.43M
Free cash flow (TTM)31.24M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity15.00%
Return on Assets7.37%
Return on Invested Capital11.26%
Cash Return on Invested Capital7.42%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open30.70
Daily high31.60
Daily low30.70
Daily Volume9K
All-time high91.00
1y analyst estimate62.15
Beta0.02
EPS (TTM)2.58
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
SLV.WARS&P500
Current price drop from All-time high-66.04%-12.89%
Highest price drop-66.26%-56.47%
Date of highest drop10 Apr 20259 Mar 2009
Avg drop from high-17.11%-11.07%
Avg time to new high22 days12 days
Max time to new high561 days1805 days
COMPANY DETAILS
SLV.WAR (Selvita S.A.) company logo
Marketcap
567.18M
Marketcap category
Small-cap
Description
Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, analytical and solid state chemistry, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, autoimmune/immunology, neurology, respiratory, and other. In addition, the company provides drug development services, including formulation development; CMC analytical support; stability and shelf-life determination; clinical supply/GMP manufacturing; small molecules bioanalysis; drug substance and product; and biologics and biosimilars bioanalysis services. Further, it offers research and development services in the areas of agrochemistry analytical support, and flavor and fragrance chemistry. Selvita S.A. was founded in 2007 and is headquartered in Kraków, Poland.
Employees
886
Investor relations
-
CEO
Country
Poland
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found